Lactulose Solution
Product Images NDC 64980-592

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Lactulose Solution (NDC 64980-592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label01 (Label01)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Rising Pharmaceuticals, Inc. The label indicates a 16 fl oz (473 mL) bottle, with administration directions and storage instructions. It shows the NDC 64980-592-48 and includes a barcode and distributor details for Rising Pharmaceuticals, Inc., East Brunswick, NJ.*

FDA Label Image

Label02 (Label02)

Prescribing information for Lactulose Solution USP 10 g/15 mL, detailing its use for oral or rectal administration in the prevention and treatment of portal-systemic encephalopathy. The text includes a chemical structure of lactulose, clinical pharmacology, indications, contraindications, warnings, precautions, drug interactions, carcinogenicity, pregnancy effects, and nursing considerations.*

FDA Label Image

Label03 (Label03)

This image is the prescribing information panel for Lactulose Solution USP 10 g/15 mL by Rising Pharma Holdings, Inc. It includes sections on indications and dosage, adverse reactions, overdose, pediatric use, rectal administration, storage instructions, and pharmacist dispensing guidelines. The 16 fl oz (473 mL) solution is indicated for oral or rectal use, with details on composition and handling precautions.*

FDA Label Image

Label04 (Label04)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Rising Pharma Holdings, Inc. The label includes dosage information, storage instructions, and a barcode. It specifies a 32 fl oz (946 mL) container and indicates Rx only status, with directions to see full prescribing information.*

FDA Label Image

Label05 (Label05)

Prescribing information for Lactulose Solution USP 10 g/15 mL details its use for oral or rectal administration in preventing and treating portal-systemic encephalopathy. The panel includes a chemical structure of lactulose, clinical pharmacology, indications, contraindications, warnings, precautions, drug interactions, carcinogenicity, pregnancy, and nursing mother considerations.*

FDA Label Image

Label06 (Label06)

Drug facts and prescribing information text panel for Lactulose Solution USP 10 g/15 mL by Rising Pharmaceuticals. The panel includes pediatric use information, adverse reactions, overdose signs and symptoms, dialysis considerations, detailed oral and rectal dosage and administration guidelines, storage instructions, and packaging details for bottles of various volumes up to 32 ounces (946 mL). It also notes the need for storage at controlled room temperature and warnings regarding darkening and turbidity.*

FDA Label Image

Label07 (Label07)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Rising Pharmaceuticals. Includes product name, strength, administration route, contents per 15 mL, storage instructions, distributor address, and a barcode. The label is for a 4 oz (118 mL) container with prescription-only status.*

FDA Label Image

Label08 (Label08)

Prescribing information for Lactulose Solution USP 10 g/15 mL, an oral or rectal solution for the prevention and treatment of portal-systemic encephalopathy. The panel includes a chemical structural formula, detailed description, clinical pharmacology, indications, and contraindications.*

FDA Label Image

Label09 (Label09)

This text panel displays warnings, precautions, drug interactions, carcinogenesis, mutagenesis, fertility impairment, and pregnancy-related information for Lactulose Solution USP, 10 g/15 mL. It highlights safety concerns including risks during procedures, effects on portal-systemic encephalopathy management, and reproductive toxicity studies outcomes.*

FDA Label Image

Label10 (Label10)

This text panel provides detailed dosage and administration instructions for Lactulose Solution USP, 10 g/15 mL, including oral and rectal routes. It includes information on dosing adjustments for adults and pediatric patients, adverse reactions, overdose symptoms, and notes on use in nursing mothers. It also addresses safety cautions and clinical considerations for portal-systemic encephalopathy.*

FDA Label Image

Label11 (Label11)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Rising Pharmaceuticals. The label includes storage instructions for controlled room temperature (20-25°C), packaging sizes of 4 oz. (118 mL), and a note that the product is Rx only. Label details dosing, contents, and warnings about storage and color changes.*

FDA Label Image

Label12 (Label12)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Rising Pharmaceuticals. The 8 oz (236 mL) bottle label includes dosage info, storage instructions (20-25°C), and distributor details for Rising Pharmaceuticals, Inc., East Brunswick, NJ. The label features a barcode and Rx only designation.*

FDA Label Image

Label13 (Label13)

Prescribing information panel for Lactulose Solution USP 10 g/15 mL details its use for oral or rectal administration in preventing and treating portal-systemic encephalopathy. It includes a structural formula of lactulose, a synthetic disaccharide, and outlines clinical pharmacology, indications, usage, and contraindications, noting galactose content and mechanism of action.*

FDA Label Image

Label14 (Label14)

This text panel for Lactulose Solution USP 10 g/15 mL provides warnings, precautions, drug interactions, carcinogenicity, mutagenesis, fertility impairment potential, and pregnancy category information. It highlights risks related to gas accumulation during procedures, cautions for diabetes, management considerations for liver disease, and the need for monitoring drug interactions.*

FDA Label Image

Label15 (Label15)

A drug information panel for Lactulose Solution USP 10 g/15 mL detailing nursing mother precautions, pediatric use, adverse reactions, overdose signs, and dosage and administration guidelines for oral and rectal routes. It includes specific instructions for adults and pediatric patients, emphasizing caution and dose adjustments.*

FDA Label Image

Label16 (Label16)

Label for Lactulose Solution USP 10 g/15 mL oral and rectal solution by Rising Pharmaceuticals, Inc. The label includes dosing information, storage instructions, and package sizes (4 oz, 8 oz, 1 pint, 32 oz) with emphasis on dispensing in child-resistant containers. The product is distributed by Rising Pharmaceuticals, Inc., East Brunswick, NJ, with an issue date of 05/2023.*

FDA Label Image

Lactulose-struc (Lactulose Struc)

Chemical structure diagram of the active ingredient lactulose, showing its two linked sugar rings with hydroxyl and oxygen groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.